Elmiron Linked to Eye Disease | Console and Associates, P C jdsupra.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jdsupra.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
MIAMI, Dec. 21, 2020 /PRNewswire/ The pharmaceutical product liability lawyers at the Law Offices of Jason Turchin are investigating claims where patients who were taking Elmiron developed maculopathy or other eye disease. Several Elmiron lawsuits have been filed around the United States and are now being consolidated in New Jersey. Elmiron, used to treat chronic bladder infection called interstitial cystitis, causes eye problems according the several lawsuits and studies.
A recent study found a possible link between long-term PPS use and the potential development of a toxic maculopathy. In June 2020, Elmiron changed its label to warn patients of the risk of certain eye issues from taking the medication. Unfortunately, by this time many patients taking Elmiron already began suffering from maculopathy, and other eye problems.
Share this article
Share this article
PORT WASHINGTON, N.Y., Dec. 18, 2020 /PRNewswire/ Parker Waichman LLP, a national law firm actively involved in the Elmiron® litigation, announced today that plaintiffs were successful in their motion,
under 28 USC § 1407, to centralize all pending Elmiron injury lawsuits filed in federal courts across the country in the District of New Jersey.
The United States Judicial Panel on Multidistrict Litigation, in the matter of In re Elmiron (pentosan polysulfate sodium) Products Liability Litigation, issued a Transfer Order (Case MDL No. 2973; Document 158) on December 15, 2020 initiating the transfer of all federally-filed Elmiron injury lawsuits to the District of New Jersey and assigning the Honorable Brian R. Martinotti to all coordinated or consolidated proceedings.